Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transurethral Periprostatectomy Treatment of Cancerous Prostate Tissue
Sponsor: Francis Medical Inc.
Summary
This goal of this clinical trial is to determine if the Vanquish System can safely and effectively treat cancerous tissue in the prostate. Researchers will also determine the best treatment dose, monitor safety during and immediately after the procedure, and examine prostate tissue after surgical removal to confirm how well the treatment destroyed targeted tissue. Patients enrolled have been diagnosed with prostate cancer and will undergo treatment with the Vanquish System before their scheduled radical prostatectomy.
Official title: Transurethral Periprostatectomy Treatment of Cancerous Prostate Tissue (Peri III Study)
Key Details
Gender
MALE
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2022-11-14
Completion Date
2023-08-11
Last Updated
2026-05-01
Healthy Volunteers
No
Conditions
Interventions
Water Vapor Ablation
Water vapor ablation delivered transurethrally in patients undergoing a radical prostatectomy for prostate cancer.
Locations (1)
C&M Research S.A.
Panama City, Provincia de Panamá, Panama